BeOne Medicines (ONC) statistics

Analysts' price targets and ratings, ownership, short interest, trading figures and dates for BeOne Medicines, as the data feed reports them.

Analysts' mean target, 27 analysts
$469.23
13.5% above the price

The 27 analysts reported by the data feed have a mean price target for BeOne Medicines of $469.23, 13.5% above the $413.26 price (range $400.00–$561.30). 1.97% of the float was sold short as of Oct 30, 2026. Institutions hold 34.6% of the shares and insiders 17.3%. Source: Yahoo Finance, read Nov 17, 2026.

Key facts

Analysts' mean target
$469.23+13.5% vs price
Analysts
27
Short interest
1.97%of float, Oct 30, 2026
Short ratio
4.32 days
Institutions
34.6%
Insiders
17.28%
Beta
0.63

Figures read . Source: Yahoo Finance (quoteSummary: key statistics, financial data, recommendation trend, major holders, insider purchases, calendar events). Analysts' targets and ratings, ownership and short interest are the data feed's figures and can lag the filings and exchange reports they come from. Figures, not advice.

Analysts' consensus as reported by the data feed

27 analysts covering BeOne Medicines, as the data feed counts them. Price targets and ratings are other people's estimates — not facts about the company, and not advice. Distances are from the latest price the feed gave with these figures, $413.26.

Analysts' price targets for BeOne Medicines
Mean price target$469.2313.5% above the price (+13.5%)
Median price target$468.6213.4% above the price (+13.4%)
Highest target$561.3035.8% above the price (+35.8%)
Lowest target$400.003.2% below the price (−3.2%)
Analysts with a target27

Ratings this month · 27 analysts

Strong buy 7(26%)Buy 19(70%)Hold 1(4%)
Analysts' ratings of BeOne Medicines this month, by rating
RatingAnalystsShare
Strong buy726%
Buy1970%
Hold14%
Sell00%
Strong sell00%

The feed averages these to 1.33 on its scale of 1 (strong buy) to 5 (strong sell), which it labels “strong buy”.

Who owns BeOne Medicines

Ownership of BeOne Medicines
Held by institutions34.6%435 institutions; percent of shares outstanding
Held by institutions, of the float41.8%
Held by insiders17.28%percent of shares outstanding
Shares outstanding105.38M
Float81.36Mshares available to trade
Insiders' net purchases, six months−358.57K9 purchases (582.15K shares), 36 sales (940.72K shares)

Percentages are of shares outstanding unless the row says float. Insiders' net purchases are shares bought minus shares sold by insiders, as the data feed totals their reported trades.

Short interest as reported by the data feed

Shares sold short and not yet covered, as of Oct 30, 2026. Short interest is counted twice a month, so this is not today's figure.

Short interest in BeOne Medicines
Shares short1.6Mas of Oct 30, 2026
Percent of float1.97%shares short ÷ float
Percent of shares outstanding1.40%shares short ÷ shares outstanding
Short ratio (days to cover)4.32shares short ÷ average daily volume

BeOne Medicines short interest from FINRA, with its history

Trading figures

Trading figures for BeOne Medicines
Beta0.63movement against the market; 1 moves with it
52-week high$424.73
52-week low$253.95
Average volume, 3 months400.19Kshares a day
Average volume, 10 days550.87Kshares a day

Questions and answers

What is the analysts' price target for BeOne Medicines (ONC)?

As reported by the data feed, the mean price target of the 27 analysts covering BeOne Medicines is $469.23, 13.5% above the latest price of $413.26. The highest target is $561.30 and the lowest $400.00. Targets are analysts' estimates, not facts about the company and not advice.

How do analysts rate BeOne Medicines stock?

Of the 27 ratings the data feed reports for the current month, 7 are strong buy, 19 buy, 1 hold, 0 sell and 0 strong sell.

How many BeOne Medicines shares are sold short?

As reported by the data feed, 1.6M shares were sold short, 1.97% of the float as of Oct 30, 2026. At the average daily volume that is 4.32 days to cover. Short interest is reported twice a month; it is not today's figure.

Who owns BeOne Medicines stock?

As reported by the data feed, institutions hold 34.6% of the shares (435 institutions) and insiders 17.3%. There are 105.38M shares outstanding, of which 81.36M are in the float.

How much does BeOne Medicines stock move with the market?

Its beta, as reported by the data feed, is 0.63: a beta above 1 means the share has tended to move more than the market, below 1 less. Over the past 52 weeks it traded between $253.95 and $424.73.

Cite this page

Funkfolio, “BeOne Medicines (ONC) statistics: analyst targets and short interest”, data as of 17 November 2026. https://funkfolio.com/stock/ONC/statistics

Underlying data: Yahoo Finance.